Limited-stage disease: optimal use of chemotherapy and radiation treatment.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2008, Pages 321-325

  Radford, John ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABVD PROTOCOL; ANTINEOPLASTIC AGENT; BLEOMYCIN; DACARBAZINE; DIAGNOSTIC AGENT; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; VINBLASTINE;

ARTICLE; CANCER STAGING; CLINICAL TRIAL; HODGKIN DISEASE; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RADIOTHERAPY; RISK ASSESSMENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DACARBAZINE; DOXORUBICIN; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY; RISK ASSESSMENT; VINBLASTINE;

EID: 67651146889     PISSN: 15204391     EISSN: None     Source Type: Journal    
DOI: 10.1182/asheducation-2008.1.321     Document Type: Article

References (0)